Showing 1 - 20 results of 54 for search 'Peter Schirmacher', query time: 0.08s
Refine Results
-
1
The Importance of Molecular Testing in the Treatment of Cholangiocarcinoma by David Malka, Alexander R. Siebenhüner, Joachim C. Mertens, Peter Schirmacher
Published 2020-11-01
Article -
2
Expression of apoptosis repressor with caspase recruitment domain (ARC) in familial adenomatous polyposis (FAP) adenomas and its correlation with DNA mismatch repair proteins, p53,... by Christoph Roser, Csaba Tóth, Marcus Renner, Esther Herpel, Peter Schirmacher
Published 2021-02-01
Article -
3
Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types by Jan Budczies, Carsten Denkert, Balázs Győrffy, Peter Schirmacher, Albrecht Stenzinger
Published 2017-12-01
Article -
4
-
5
-
6
-
7
-
8
-
9
Propofol-Induced Hepatitis by Hanna Raisi, Thomas Longerich, Bernardo Moreira Assuncao, Sebastian Mueller, Peter Schirmacher, Helmut-Karl Seitz
Published 2020-10-01
Article -
10
Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study by Wolfgang Schuette, Peter Schirmacher, Wilfried E. E. Eberhardt, Manfred Dietel, Ute Zirrgiebel, Lars Muehlenhoff, Michael Thomas
Published 2018-02-01
Article -
11
-
12
SWI/SNF-deficient undifferentiated/rhabdoid carcinoma of the gallbladder carrying a POLE mutation in a 30-year-old woman: a case report by Tiemo S. Gerber, Abbas Agaimy, Arndt Hartmann, Michael Habekost, Wilfried Roth, Albrecht Stenzinger, Peter Schirmacher, Beate K. Straub
Published 2021-06-01
Article -
13
Hepatic stellate cells limit hepatocellular carcinoma progression through the orphan receptor endosialin by Carolin Mogler, Courtney König, Matthias Wieland, Anja Runge, Eva Besemfelder, Dorde Komljenovic, Thomas Longerich, Peter Schirmacher, Hellmut G Augustin
Published 2017-06-01
Article -
14
-
15
-
16
Integrated analysis of the immunological and genetic status in and across cancer types: impact of mutational signatures beyond tumor mutational burden by Jan Budczies, Anja Seidel, Petros Christopoulos, Volker Endris, Matthias Kloor, Balázs Győrffy, Barbara Seliger, Peter Schirmacher, Albrecht Stenzinger, Carsten Denkert
Published 2018-12-01
Article -
17
Lipid Droplet-Associated Proteins Perilipin 1 and 2: Molecular Markers of Steatosis and Microvesicular Steatotic Foci in Chronic Hepatitis C by Selina Schelbert, Mario Schindeldecker, Uta Drebber, Hagen Roland Witzel, Arndt Weinmann, Volker Dries, Peter Schirmacher, Wilfried Roth, Beate Katharina Straub
Published 2022-12-01
Article -
18
Autoimmune pancreatocholangitis, non-autoimmune pancreatitis and primary sclerosing cholangitis: a comparative morphological and immunological analysis. by Irene Esposito, Diana Born, Frank Bergmann, Thomas Longerich, Thilo Welsch, Nathalia A Giese, Markus W Büchler, Jörg Kleeff, Helmut Friess, Peter Schirmacher
Published 2008-01-01
Article -
19
Serum Response Factor (SRF) Drives the Transcriptional Upregulation of the MDM4 Oncogene in HCC by Rossella Pellegrino, Abhishek Thavamani, Diego F. Calvisi, Jan Budczies, Ariane Neumann, Robert Geffers, Jasmin Kroemer, Damaris Greule, Peter Schirmacher, Alfred Nordheim, Thomas Longerich
Published 2021-01-01
Article -
20
Decoy Receptor 3 Is a Prognostic Factor in Renal Cell Cancer by Stephan Macher-Goeppinger, Sebastian Aulmann, Nina Wagener, Benjamin Funke, Katrin E. Tagscherer, Axel Haferkamp, Markus Hohenfellner, Sunghee Kim, Frank Autschbach, Peter Schirmacher, Wilfried Roth
Published 2008-10-01
Article